MUC16 and ovarian carcinoma: These mAbs give predominantly cytoplasmic staining in serous and serous papillary ovarian adenocarcinoma cases, with one of the mAbs giving equivalent sensitivity to that of CA125 antibody in human ovarian cancer tissues.